Can zapping an extra vein stop atrial fibrillation better?

NCT ID NCT07724899

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial investigates whether isolating the superior vena cava, in addition to the standard pulmonary vein isolation, improves success rates for treating atrial fibrillation. Using a newer, safer energy source called pulsed field ablation, the study compares the two procedures in 200 adults with documented AF. The goal is to see if targeting non-pulmonary vein triggers can reduce recurrence without added harm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pulsed field ablation procedure to isolate the superior vena cava and pulmonary veins
What this could lead to
If successful, this approach could reduce atrial fibrillation recurrence by targeting an additional trigger site beyond the standard pulmonary vein isolation.
What could go wrong
This is a single-center trial with 200 participants, and the added isolation may not improve outcomes or could increase procedure risks like phrenic nerve injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Qiang Hu

    RECRUITING

    Chengdu, Sichuan, 610000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.